TerminatedNot Applicable

A Sticker Reminder Intervention to Promote IV-to-PO Fluoroquinolone Switching

Stopped: Slow recruitment

Thailand168 participantsStarted 2020-07-01

Plain-language summary

A single-center, cluster-randomized controlled trial was conducted to determine the effect of Sticker reminder intervention on IV-to-PO switching of fluoquinolone.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients (aged ≥ 18 years)
✓. Diagnosis of any infection
✓. Receiving at least one dose of intravenous fluoroquinolones (ciprofloxacin, levofloxacin, or moxifloxacin)

Exclusion criteria

✕. Inability to tolerate oral medications (e.g., due to severe nausea/vomiting, malabsorption, active gastrointestinal bleeding, or severe diarrhea);
✕. Being in an immunodeficiency state (e.g., neutropenia \[absolute neutrophil count ≤ 500 cells/mm3\], symptomatic HIV/AIDS, history of bone marrow or organ transplantation, leukemia, or current use of immunosuppressive agents); or
✕. Having severe infections requiring exclusive intravenous antimicrobial therapy (e.g., infective endocarditis, meningitis, encephalitis, brain abscess, or prosthetic device infections).

What they're measuring

IV-to-PO switching

Timeframe: From the day of initiation of fluoroquinolone to the discharge date (Up to 1 year)

Trial details

NCT IDNCT07361185

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Fluoroquinolone trials